Jason Kidd, MD
Nephrology · Richmond, VANPI 1588824551
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,042 of the $12,630 with a category attached, or 79.5%. 7 manufacturers reported payments, led by Travere Therapeutics, Inc. at 57.3% of the total. 2025 is the largest year on record at $7,209, more than ten times the $122 reported in 2019. Among nephrology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $382.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$7K
- Amgen$5K
- Novartis$207
- Akebia Therapeutics Inc$125
- Sanofi$65
- Nxstage Medical, Inc.$57
- plus $17 from 1 others
Across 21 payments — averaging $7932.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$104K
- Hoffmann-la Roche Limited$34K
- Novartis$29K
What the payments were for
- Consulting fees$10,04280%
- Speaking & faculty fees$9868%
- Travel & lodging$6095%
- Food & beverage$9568%
- Education$370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 24 | $7,231 |
| Amgen | 3 | $4,928 |
| Novartis | 2 | $207 |
| Akebia Therapeutics Inc | 1 | $125 |
| Sanofi | 1 | $65 |
| Nxstage Medical, Inc. | 1 | $57 |
| Novo Nordisk | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,630 in reported general payments places this provider in the 90th percentile of 298 nephrology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 32 | $65,213 |
| FarxigaDapagliflozin Propanediol | 46 | $49,301 |
| JardianceEmpagliflozin | 30 | $37,211 |
| Midodrine Hcl | 22 | $34,242 |
| EliquisApixaban | 23 | $22,220 |
| Sevelamer Carbonate | 83 | $16,526 |
| Lanthanum Carbonate | 13 | $14,162 |
| Tacrolimus | 36 | $4,065 |
| Mycophenolate Mofetil | 12 | $1,990 |
| Nifedipine ErNifedipine | 59 | $1,746 |
| Potassium Chloride | 55 | $1,310 |
| Chlorthalidone | 81 | $1,168 |
| Losartan Potassium | 136 | $1,013 |
| Amlodipine Besylate | 123 | $942 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $922 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Richmond
- Gaurav GuptaRichmond$168K
- Todd GehrRichmond$17K
- Nilang PatelRichmond$13K
- Domenic SicaRichmond$10K
- Dhiren KumarRichmond$8K
- Lozina DanevaRichmond$7K
- Ari HirschRichmond$6K
- Shreyank TripathiRichmond$5K
- Sandy GibsonRichmond$5K
- Richard GayleRichmond$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.